“Bimekizumab Safety in Patients With Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s21, https://doi.org/10.25251/skin.5.supp.21.